Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion type Assertion NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_head.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion description "[Marked increased expression of cyclooxygenase 2 (COX-2), a prostaglandin-synthesizing enzyme that is pharmacologically inhibited by nonsteroid anti-inflammatory-type drugs, is a major early oncogenic event in the genesis of human colon neoplasia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_provenance.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion evidence source_evidence_literature NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_provenance.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion SIO_000772 15574495 NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_provenance.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion wasDerivedFrom befree-20140225 NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_provenance.
- NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_assertion wasGeneratedBy ECO_0000203 NP276995.RAkRP5S7H1p1EEhTZJN6mSe4hzgbFSDvzEXWzF-U1RHso130_provenance.